Laboratory Co. of America (LH) to Release Earnings on Thursday

Laboratory Co. of America (NYSE:LH - Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Thursday, February 6th. Analysts expect the company to announce earnings of $3.40 per share and revenue of $3.31 billion for the quarter. Persons interested in registering for the company's earnings conference call can do so using this link.

Laboratory Co. of America Stock Performance

Shares of NYSE:LH traded up $7.74 during midday trading on Thursday, reaching $253.96. 361,393 shares of the company's stock traded hands, compared to its average volume of 543,878. Laboratory Co. of America has a one year low of $191.97 and a one year high of $258.59. The stock has a 50 day moving average of $235.60 and a 200 day moving average of $228.09. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.30 and a current ratio of 1.44. The company has a market cap of $21.24 billion, a price-to-earnings ratio of 49.06, a P/E/G ratio of 1.81 and a beta of 1.06.

Laboratory Co. of America Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 12th. Shareholders of record on Thursday, February 27th will be paid a dividend of $0.72 per share. The ex-dividend date is Thursday, February 27th. This represents a $2.88 dividend on an annualized basis and a yield of 1.13%. Laboratory Co. of America's dividend payout ratio is presently 55.71%.

Insider Activity

In other news, EVP Glenn A. Eisenberg sold 11,711 shares of the company's stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $240.43, for a total transaction of $2,815,675.73. Following the completion of the sale, the executive vice president now owns 31,289 shares of the company's stock, valued at $7,522,814.27. This represents a 27.23 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Kerrii B. Anderson sold 1,000 shares of the business's stock in a transaction dated Tuesday, January 7th. The stock was sold at an average price of $235.00, for a total transaction of $235,000.00. Following the transaction, the director now owns 12,722 shares in the company, valued at $2,989,670. The trade was a 7.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 24,572 shares of company stock worth $5,915,209 in the last quarter. Corporate insiders own 0.85% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. HSBC upgraded shares of Laboratory Co. of America from a "hold" rating to a "buy" rating in a research note on Wednesday, October 30th. Evercore ISI raised Laboratory Co. of America from an "in-line" rating to an "outperform" rating and boosted their price target for the company from $260.00 to $265.00 in a report on Tuesday, January 7th. StockNews.com downgraded Laboratory Co. of America from a "buy" rating to a "hold" rating in a research note on Friday, October 25th. Hsbc Global Res raised shares of Laboratory Co. of America from a "hold" rating to a "strong-buy" rating in a report on Wednesday, October 30th. Finally, Piper Sandler lifted their price target on shares of Laboratory Co. of America from $235.00 to $240.00 and gave the company a "neutral" rating in a report on Monday, October 28th. Four research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, Laboratory Co. of America currently has a consensus rating of "Moderate Buy" and a consensus target price of $261.77.

Laboratory Co. of America Company Profile

Labcorp Holdings, Inc engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.